CHKA and colonic neoplasm: Furthermore, using a PI3K inhibitor, PI-103, Al-Saffar et al. were able to demonstrate downregulation of CK levels in prostate and colon cancers, with a corresponding decrease in PC levels (Al-Saffar et al., 2010).